PIP3 antagonist as a molecular regulator in MSC-derived cardiomyocytes: Potential in vitro therapeutic implications for conotruncal heart defects.

publication — a durable, citable reference into the African DSI DataBank's federated catalog.

publicrestrictedorigin: hub

Last updated 9/17/2026, 4:09:04 AM

Cite this record

African DSI DataBank. PIP3 antagonist as a molecular regulator in MSC-derived cardiomyocytes: Potential in vitro therapeutic implications for conotruncal heart defects.. AFDSI-PUB-1091. 2026. https://hub.africandsidatabank.africa/cite/AFDSI-PUB-1091 Mirrored from data source: PubMed: https://pubmed.ncbi.nlm.nih.gov/42749427/.

BibTeX

@misc{AFDSIPUB1091,
  title        = {PIP3 antagonist as a molecular regulator in MSC-derived cardiomyocytes: Potential in vitro therapeutic implications for conotruncal heart defects.},
  author       = {{African DSI DataBank}},
  year         = {2026},
  howpublished = {\url{https://hub.africandsidatabank.africa/cite/AFDSI-PUB-1091}},
  note         = {African DSI DataBank citable identifier AFDSI-PUB-1091; Mirrored from data source: PubMed: https://pubmed.ncbi.nlm.nih.gov/42749427/}
}

AFDSI-PUB-1091 is a stable, resolvable local identifier — not a registered DOI. See Terms of use's "Citation policy" for the full explanation.